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Abstract
Medication adherence is a complex behaviour with multiple determinants. Understanding the barriers and facilitators of adherence 
is invaluable for programme improvement, which assists the foundation of adherence intervention strategies. A qualitative study 
was conducted in six selected hospitals of Addis Ababa in 2008, to explore barriers and facilitators to antiretroviral medication 
adherence among HIV-infected paediatric patients. Twelve caregivers of adherent and non-adherent children and 14 key informants 
in five hospitals were included in the study.  The findings revealed that over-dosage (heavy pill burden), fear of stigma and 
discrimination, cost and access to transportation, lack of understanding of the benefit of taking the medication, economic problems 
in the household, and lack of nutritional support were the barriers to adherence to HAART. The presence of mobile/wall alarm, the 
presence of follow-up counselling, improved health of the child, ART clinic setups, and disclosure of HIV serostatus were among the 
facilitators. This study indicated that paediatric adherence to antiretroviral therapy faces a huge challenge. It suggests the provision 
of income-generating schemes to caregivers for assisting HIV-infected children. Health care providers should address proper usage 
of medication reminders.
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Barriers and facilitators to antiretroviral medication adherence among HIV-infected 
paediatric patients in Ethiopia: A qualitative study
Sibhatu Biadgilign, Amare Deribew, Alemayehu Amberbir, Kebede Deribe
Résumé 
L’adhésion à un traitement médical est un comportement complexe aux déterminants multiples. La compréhension des obstacles 
à l’adhésion et ses facilitateurs sont inestimables pour l’amélioration des programmes contribuant à la fondation des stratégies 
d’intervention en matière d’adhésion. Une étude qualitative a été réalisée dans huit hôpitaux sélectionnés d’Addis-Abeba en 2008 
afin d’explorer les obstacles à l’adhésion au traitement antirétroviral et ses facilitateurs chez les patients en pédiatrie infectés 
par le VIH. Douze soignants d’enfants adhérant et n’adhérant pas au traitement et 14 informateurs clés dans cinq hôpitaux ont 
participé à l’entretien.  Les conclusions ont révélé que le surdosage (charge en pilule lourde), la peur de la stigmatisation et de la 
discrimination, le coût des transports et leur accès, l’absence d’une compréhension des bénéfices à prendre des médicaments, les 
problèmes économiques que rencontrent les ménages et l’absence de soutien nutritionnel constituaient des barrières à l’adhésion au 
traitement HAART. La présence d’une alarme mobile/murale, la fourniture d’une assistance psychosociale de suivi, la meilleure santé 
de l’enfant, les configurations cliniques de l’ART et la divulgation du statut sérologique faisaient partie des facilitateurs. Cette étude a 
indiqué que l’adhésion pédiatrique à la thérapie antirétrovirale se trouvait confrontée à un défi considérable. Cela nécessite la création 
d’un schéma de génération de revenus aux soignants pour aider les enfants infectés par le VIH. Les fournisseurs de soins de santé 
devraient traiter l’utilisation correcte des médicaments en surplus.
Mots clés: VIH/SIDA, adhésion, thérapie antirétrovirale, enfants, Ethiopie.
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Introduction
Worldwide, about 2.3 million children are infected with HIV, of 
whom nearly 90% are in sub-Saharan Africa (UNAIDS/WHO, 
2006). In 2006 alone, new infections in children under 15 years 
were estimated to be 530 000 (410 000 - 660 000) and there were 
380 000 deaths (UNAIDS/WHO, 2006). It is currently estimated 
that 1 600 children are infected every day (UNAIDS, 2004). 
During the last few years, the introduction of highly active 
antiretroviral therapy (HAART) has dramatically changed the 
natural course of HIV infection (Hogg et al., 1998; Palella et al., 
1998).
Research indicates that consistently high levels of adherence 
are necessary for reliable viral suppression (Bangsberg et al., 
2000; Paterson et al., 2000), prevention of resistance (Bangsberg 
et al., 2003), and disease progression (Bangsberg et al., 2001). 
Along with this, many factors can affect the ability of HAART 
to suppress viral replication, including low potency of one of 
the drugs in the combination, viral resistance, inadequate drug 
exposure and inadequate adherence to therapy. The major factor 
determining the success of HAART is sustained and optimum 
adherence to therapy (Starace, Massa, Amico, & Fisher, 2006), 
as poor adherence increases the risk of virological failure and 
viral resistance (Nischal, Khopkar, & Saple, 2005).
Sustaining adherence represents a significant challenge for 
children receiving treatment and for their caregivers. In order to 
facilitate adherence and improve outcome of HAART in HIV-
infected children it is necessary to identify potential relevant 
issues in paediatric patients that influence adherence, and to 
determine the possible interventions to improve adherence in 
children (Shah, 2007). There is a paucity of reports on HAART in 
children from resource-poor settings. Therefore, understanding 
of barriers and facilitators helps in planning interventions to 
address adherence concerns. The objective of this study was 
to explore the barriers and facilitators to HAART adherence 
among HIV-infected children. 
Methods 
Study setting 
The study was conducted in selected hospitals in Addis Ababa, 
the capital city of the Federal Democratic Republic of Ethiopia. 
In 2008 the total number of children on ART in Ethiopia was 
5 245 (Federal Ministry of Health / HIV/AIDS Prevention and 
Control Office, 2008). The study was carried out in selected 
antiretroviral therapy units in Addis Ababa hospitals including 
Black Lion, St Peter, Yekatit 12, Zewditu, and ALERT Hospitals. 
Among these, Black Lion Hospital is a teaching hospital under 
the Federal Ministry of Education; St Paul Hospital is a general 
specialised hospital under the Federal Ministry of Health; St 
Peter Hospital is a generalised hospital for TB treatment and 
recently opened an ART clinic for adults and children; ALERT 
Hospital is also under the Federal Ministry of Health; and 
Yekatit 12 and Zewditu hospitals are under the Addis Ababa 
Regional Health Bureau, known to serve most of the patients 
on ART follow-up. The study was conducted from 18 February 
to 28 April 2008. 
Design and participants
For this study, two population groups were chosen to be 
interviewed. The first group was patients who had received 
continuous antiretroviral therapy for the previous 12 weeks 
before the study in the selected hospitals, with caregivers 
who were parents or guardians who were counselled on the 
importance of drug adherence. In addition, this group needed to 
present for follow-up during the data collection period.  In-depth 
interviews were undertaken with the caregivers in six selected 
adherent and six selected non-adherent cases of children with 
diverse socioeconomic and demographic characteristics (Table 
1). Participants were eligible for the study if they expressed a 
willingness to share their views on adherence to ART. The 
second group was individuals involved in or supporting the 
provision of treatment and care for patients on ART. These 
individuals consisted of 14 key informants, eight counsellors 
and four physicians, including two paediatricians (Table 2). 
The number of interviews was determined by saturation of 
data (successive interviews become repetitive and redundant 
so that no new information can be gathered by further data 
collection). A purposive sampling technique was carried out to 
select the participants. The key informants were selected based 
on exposure to children in all circumstances, their ability to 
appreciate the problems of adherence, and their perceptions of 
what helps and/or hinders patients from taking ART regularly, 
as well as capability to suggest intervention mechanisms for 
improving adherence to ART. 
Table 1. Characteristics of health care pro-
viders (N=14) 
Characteristics  Number 
Age in years 
   20 - 29 8
   30 - 39 6
Sex
   Male 4
   Female 10
Professionals 
   counsellor 8
   Physician 4
   Paediatrician 2
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Data collection
In-depth interviews were conducted by the principal investigator 
with caregivers of HIV-positive children and health workers, 
including counsellors and paediatrician. An interview guide 
was used, which consisted of open-ended questions related 
to broad subject areas regarding: knowledge of the disease 
and its treatment, factors that influence adherence, personal 
perspectives of the medication, and barriers and facilitators of 
patient adherence to treatment. The interviews were conducted 
in a hospital setting that was convenient for key informants as 
well as caregivers. The level of adherence was assessed by self-
report (of the primary caregiver). Field notes were written at 
the conclusion of each interview and all tapes were transcribed. 
Ethical clearance was obtained from Jimma University and 
Addis Ababa Health Bureau. Caregivers were informed that 
refusing to participate in the study would not affect their access 
to treatment. All participants who were interviewed individually 
gave consent.
Data analysis 
The interview data were analysed manually, using thematic 
content analysis. This approach is a comparative process by 
which the various accounts gathered are compared with each 
other to classify those ‘themes’ that recur or are common in 
the data set (Green, & Thorogood, 2004). All transcripts were 
read several times by the investigators separately to bring out 
the main ideas, barriers and facilitators of adherence. Later 
the data were reviewed and combined into broader categories 
in terms of key variables; the information was then ordered, 
reduced and classified or coded, displayed, summarised and 
finally interpreted. Identification of barriers and facilitators 
of ART adherence were evaluated according to the principles 
of phenomenological analysis, in that inquiry aimed to fully 
describe the lived experience of those children who took 
antiretroviral therapy, as well as the perceptions of the caregivers 
on the barriers and facilitators in day-to-day life (Polit & Beck, 
2004). 
Results
In this study several barriers and facilitators of paediatric 
adherence were identified. These factors are presented below. 
Key barriers  
Caregiver factors/characteristics 
From all the in-depth interviews with caregivers and health 
care providers, reasons for missing health facility appointments 
include caregivers visiting holy water places or another area 
outside of their place of residence.  A 34-year-old female 
caregiver reported a reason for not giving the medication as 
leaving home to visit relatives: 
I was visiting my relatives in rural area as a result of my 
mother’s death. I left the child with his grandfather. He is very 
old to follow-up.
Potential barriers to adherence include non-disclosure of HIV 
status, poverty and nutritional problems, lack of social support, 
and absence of a private place to take the medicine when 
relatives /neighbours came to their home, for fear of stigma and 
discrimination. Both the caregivers and health care providers 
reported non-disclosure as a significant barrier in handling 
HIV-infected children: 
I have worked in this hospital for several years. Most of 
the time the children do not know their serostatus, and 
this results in difficulties of treating HIV infected children.   
(28-year-old female nurse, in hospital setting) 
The majority of caregivers reported a common barrier as 
moving from house to house, as most of them did not have their 
own house. Many caregivers experienced problems like access 
to transportation, and economic problems in the household:  
My family didn’t have adequate money to spend toward 
the child’s transportation; I came from a long distance. We 
usually come on foot.  (43-year-old grandfather of non-
adherent children) 
Table 2. Characteristics of caregivers (N=12) 
Characteristics  Number 
Caregivers  
    Adherent 6
   Non-adherent  6
Age in years 
   20 - 29 4
   30 - 39 3
   40 - 49 5
Sex
   Male 5
   Female 7
Occupation 
   Merchant 1
   Governmental employee 3
   Day labourer 4
   Jobless/ housemaid 4
Marital status 
   Single 1
   Married 5
   Divorced 3
   Widowed  3
Educational status 
   Grade 0 - 7  6
   Grade 8 -12  4
   Diploma and above 2
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As explained by the caregivers, nutritional problems were a 
common barrier to patient adherence to medication regimens. 
The issue of food security is a prerequisite for the initiation, as 
well as the continuation of the treatment. One 32-year-old male 
caregiver expressed this idea in few words: no food, no drug to 
take. 
A 28-year-old female nurse counsellor from one of the hospitals 
stated the situation as follows: 
There is no food /nutrition in the households, so the children 
are not taking the medication. As most of the caregivers are 
HIV positive, they don’t have any food to eat for themselves 
let alone their children.
The health care providers described the issue of barriers to 
adherence from the caregivers’ perspective. They described 
the caregivers of non-adherent children as grandparents, less 
educated, or having a lack of understanding of the benefits of 
taking of the medication. Children did no have the capacity and 
ability to take the medication; hence, this is a critical component 
of the administration of the drugs. However, caregivers were 
reportedly unconvinced that these matters could affect the 
medication adherence of the children. 
Providers found a significant challenge in adherence counselling 
due to the fears of stigma and discrimination that caregivers 
possess. A 27-year-old male health care provider stated:
At the time the child should take the drugs he/she is not given 
them since relatives are at home. The child immediately goes 
to the bedroom without taking his/her medication.
Medication-related factors 
Most of the caregivers and health care workers reported the 
high dosages (heavy pill burden), patient dislike of taking the 
medication, and the children spitting out the medication as 
causes of poor adherence to the medication regimens. Caregivers 
also reported that the time of administration of the prescribed 
drugs was conflicting with normal working hours.
Caregivers’ and health care providers’ relationship 
Counsellors stressed the importance of the physician’s 
communication of the importance of ART adherence. In 
the initial phase, before the start of treatment, there might 
be problems in communication between patients and 
providers. However, repeated counselling could lead to better 
understanding among caregivers. One problem in patient-
provider relationships in treating HIV-infected children was the 
rotation of residents in the hospital setting, particularly in two 
of the teaching hospitals:   
As they shift, the child may be seen by different physicians 
throughout his /her treatment course ... that poses a challenge. 
(30-year-old female nurse counsellor)
I already gave the whole history of my child to the physician 
one year ago but still the new  physician  asks the child’s 
status now and then ... it is boring   (37-year-old government 
employed male caregiver) 
Key facilitators 
Both the caregivers and health care providers reported facilitators 
of adherence to prescribed medication as:  equipment for 
children to play with in hospitals; the presence of both parents 
alive at home with the child; the receipt of ongoing counselling 
to the caregivers on adherence; disclosure of the diagnosis of 
HIV to the child; a well-educated caregiver; and seeing the 
improvement in quality of life in the children. The majority of 
the children came to the hospital without missing their follow-
up appointments because they felt content in the hospital setting 
and they were able to play with children of the same age group:
Children have an opportunity to draw a picture, paint on 
paper, and have a good relationship with us in this manner 
(28-year-old female nurse counsellor in hospital setting) 
The other facilitator identified by respondents was the presence 
of medication reminders. A 29-year-old male caregiver noted: 
I use a calendar for memorising/reminding me of the time 
the drugs should be given.
The most common denominator for facilitating adherence was 
the approach of the health worker toward the caregiver at all 
times, in order to enhance the dialogue process: 
... Approach and deep understanding of the caregiver during 
discussion is vital for the smoothness of the communication 
process. (32-year-old female hospital paediatrician) 
Successful strategies for improving 
adherence 
During interviews participants not only identified barriers and 
facilitators to adherence, but also developed specific strategies 
to overcome barriers that they had. Several patients believed 
that improving their communication with their providers was 
a feasible and important goal in improving adherence. Health 
care professionals pointed out strategies to be recommended 
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for improving adherence to antiretroviral therapy, including 
educating the community about adherence as well, disclosure 
of HIV status to children as early as possible based on the 
developmental stage of the child. Others explained the 
importance of providing income-generating schemes and 
harmonisation of the work rendered by non-governmental 
organisations. Moreover, patient-provider interaction should 
be encouraged before the commencement of the medication, in 
order to improve adherence. Enhancing the psychological make-
up of the caregivers is of importance, as continued education 
for illiterate attendants and counselling might help improve 
adherence. The majority of adherent caregivers indicated that 
early clinical visits to the hospital helped them to monitor and 
control their medication in a better way. 
Discussion
Resource-limited settings present unique challenges to ART 
adherence. A multitude of structural barriers prevent access to 
health care and the regular supply of antiretroviral drugs. These 
include the cost of medical care, drugs, and the difficulty of 
making follow-up appointments due to long distances, family 
responsibilities, and the prohibitive cost of transportation 
(Mukherjee et al., 2006). This finding is consistent with our 
findings, in that cost of transportation becomes a huge burden 
to the family, so the family income becomes a major barrier for 
sustained treatment with ART in low-income countries. Again, 
this is supported by a body of literature (Bangsberg , Ware, & 
Simoni, 2006; Byakika-Tusiime et al., 2005; Lanièce et al., 2003; 
Nachega et al., 2004; Weiser et al., 2003).
Nutritional support was found to be a significant contributor 
to medication adherence, as lack of nutritional support at the 
health facilities level emerged as an important factor for ART 
non-adherence in our study. In similar fashion, other qualitative 
studies found that food security was a barrier to successful 
utilisation of HAART (Howland et al., 2000; Martinez et al., 
2000). This is a critical factor in implementation of an ART 
programme, so that it is imperative to take a look at nutritional 
support as a precursor to ART uptake leading to better 
adherence. In addition, in this study, housing instability was 
demonstrated as a barrier, which is consistent with Martinez et 
al. (2000) and Howland et al. (2000), who identified negative 
life events (e.g. housing instability, poverty) and economic 
instability as significant factors in predicting adherence. This 
has important implications, as participants who could secure 
stability concerning financial matters were more likely to take 
their medication regularly.
The present study’s findings suggest that HIV serostatus 
disclosure influences adherence to ART regimens for some 
HIV-positive children. This is supported by a study of HIV-
infected adults, which found that the most frequent reasons 
for non-adherence reflected general concerns about treatment 
as a reminder of one’s HIV status, not wanting other people to 
know one’s HIV status, and difficulty remembering to ask health 
care providers questions about treatment (Catz, Kelly, Bogart, 
Benotsch, & McAuliffe, 2000).This is probably due to the fear 
of stigma and discrimination attached to taking medication at 
home, as relatives or neighbours might be present at the time. 
The majority of participants listed being away from home 
and getting holy water for themselves and their children as 
reasons for not providing medication. Various other studies 
support the finding that being away from home is a barrier to 
medication adherence (Laws, Wilson, Bowser, & Kerr, 2000; 
Ryan, & Wagner, 2003; Witteveen, & van Ameijden, 2002). The 
number of medications prescribed has also been found to affect 
adherence (Samet et al., 1992), which was consistent with our 
findings. 
In our study, physician communication with patients was 
successful as reported by both nurse counsellors and caregivers, 
but problems arose in selected hospitals where physician 
rotation presented a potential gap between physician and 
caregiver.  An expanded view that takes account of this fact 
is that poor provider-patient relationships have an impact on 
adherence (Okuno, Yanagi, & Tomura, 2001). Many of the study 
participants interviewed identified the presence of medication 
reminders as methods that successfully helped them to 
remember their prescribed medication. Similar findings have 
been documented in studies carried out by Adam, Maticka-
Tyndale and Cohen (2003) and Lyon et al. (2003), which also 
found little support for using cue-based strategies to improve 
adherence among children and adolescents with HIV. 
This study has several important strengths. The identification 
of both the barrier and facilitator questions was selected 
systematically from different bodies of literature, and the 
participants represented varied patient populations in order 
to strengthen the conclusions of this study. Qualitative studies 
are well suited to identifying patient-important barriers 
and facilitators: the use of an in-depth interview approach 
permitted us to discover a diversity of ideas and practices which 
most likely would not have been detected using a quantitative 
approach. Additionally, complementing patient information 
with provider information enables a more complete picture of 
adherence issues. The study encompassed the major reference 
paediatric ART hospitals in Ethiopia, enabling a broad 
sampling of geographical variability as well as socio-cultural 
phenomena that are associated with culturally relevant barriers 
to adherence. Finally, the findings of this study hold significance 
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relevant to the developing world as there is a paucity of such 
studies in low-income countries (Mills, Nachega et al., 2006). 
Despite this, the study had some limitations. The findings from 
this study reflect the caregiver’s perceptions of reported barriers 
and facilitators of adherence to antiretroviral therapy. The cross-
sectional nature of the interviews limited our ability to assess 
changes in adherence, while adherence is a dynamic process not 
to be predicted at a single point in time. A qualitative study may 
limit the generalisability of findings, yet be relevant for idea/
hypothesis generation concerning further research. 
In conclusion, paediatric adherence to antiretroviral therapy 
faces huge challenges in the future. Disclosure of HIV status, 
food insecurity, costs of transportation, housing instability, 
medication factors, and patient-provider communication were 
found to be of major concern among caregivers and providers. 
This highlights the importance of income-generating schemes 
for the caregiver in assisting HIV-infected children.  Also, health 
care providers should address proper usage of alarms and mass 
media for medication reminders. The health worker should 
stress ART drug adherence, health education should be tailored 
in mass media to the community, and provision of nutritional 
support to the caregiver should be stressed as well. Though the 
challenges are large, they are by no means insurmountable, 
and the identification of facilitators and barriers to patient 
medication adherence is a start in finding solutions for our 
paediatric patients on ART therapy.  
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